HSV neutralization by the microbicidal candidate C5A.

PLoS One

The Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

Published: May 2011

Genital herpes is a major risk factor in acquiring human immunodeficiency virus type-1 (HIV-1) infection and is caused by both Herpes Simplex virus type 1 (HSV-1) and HSV-2. The amphipathic peptide C5A, derived from the non-structural hepatitis C virus (HCV) protein 5A, was shown to prevent HIV-1 infection but neither influenza nor vesicular stomatitis virus infections. Here we investigated the antiviral function of C5A on HSV infections. C5A efficiently inhibited both HSV-1 and HSV-2 infection in epithelial cells in vitro as well as in an ex vivo epidermal infection model. C5A destabilized the integrity of the viral HSV membrane. Furthermore, drug resistant HSV strains were inhibited by this peptide. Notably, C5A-mediated neutralization of HSV-1 prevented HIV-1 transmission. An in vitro HIV-1 transmigration assay was developed using primary genital epithelial cells and HSV infection increased HIV-1 transmigration. Treatment with C5A abolished HIV-1 transmigration by preventing HSV infection and by preserving the integrity of the genital epithelium that was severely compromised by HSV infection. In conclusion, this study demonstrates that C5A represents a multipurpose microbicide candidate, which neutralizes both HIV-1 and HSV, and which may interfere with HIV-1 transmission through the genital epithelium.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3089603PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0018917PLOS

Publication Analysis

Top Keywords

hiv-1 transmigration
12
hsv infection
12
hsv
8
hiv-1
8
hiv-1 infection
8
hsv-1 hsv-2
8
epithelial cells
8
hiv-1 transmission
8
genital epithelium
8
c5a
7

Similar Publications

Role of Monocyte/Macrophages in the Pathogenesis of NeuroHIV.

Results Probl Cell Differ

October 2024

Department of Neurobiology, The University of Texas Medical Branch (UTMB), Galveston, TX, USA.

Article Synopsis
  • Monocyte/macrophages are important immune cells that originate from myeloid cells and are involved in defending the body against infections as well as helping with healing processes.
  • Recent research has highlighted their involvement in both acute and chronic HIV infections, suggesting that they play a significant role in these conditions.
  • The discussion will center around how these cells migrate within the body and their potential function as reservoirs for the HIV virus.
View Article and Find Full Text PDF

Targeting monocytic Occludin impairs transendothelial migration and HIV neuroinvasion.

EMBO Rep

August 2024

CNRS, Institut de Recherche en Infectiologie de Montpellier (IRIM), Montpellier, France.

Transmigration of circulating monocytes from the bloodstream to tissues represents an early hallmark of inflammation. This process plays a pivotal role during viral neuroinvasion, encephalitis, and HIV-associated neurocognitive disorders. How monocytes locally unzip endothelial tight junction-associated proteins (TJAPs), without perturbing impermeability, to reach the central nervous system remains poorly understood.

View Article and Find Full Text PDF

Modeling HIV-1 Infection in CNS via Infected Monocytes Using Immunocompetent Brain Organoids.

Methods Mol Biol

May 2024

Department of Infectious Diseases and Microbiology, School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.

The development of 3D-organoid models has revolutionized the way diseases are studied. Recently, our brain organoid model has been shown to recapitulate in in vitro the human brain cytoarchitecture originally encountered in HIV-1 neuropathogenesis, allowing downstream applications. Infected monocytes, macrophages, and microglia are critically important immune cells for infection and dissemination of HIV-1 throughout brain during acute and chronic phase of the disease.

View Article and Find Full Text PDF
Article Synopsis
  • HIV persists in the central nervous system (CNS) of people living with HIV, leading to cognitive impairments even with antiretroviral therapy (ART).
  • Researchers analyzed paired cerebrospinal fluid (CSF) and blood samples from 19 untreated adults, finding higher HIV RNA levels in plasma compared to CSF and mostly consistent coreceptor usage.
  • The study revealed that some viruses in the CNS can replicate in microglia (brain immune cells) as well as T-cells, suggesting that viral evolution may help the infection spread within the CNS, which needs further investigation.
View Article and Find Full Text PDF

The blood-brain barrier (BBB) mediates cellular and molecular passage between the central nervous system (CNS) and peripheral circulation. Compromised BBB integrity has been linked to neurocognitive deficits in multiple diseases and various infections, including those associated with HIV-1 infection. Understanding the impact of exposure to pharmaceuticals, such as those utilized for pain management by patients suffering from CNS disease, on BBB regulation and function is clinically important.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!